Literature DB >> 23885079

Detection of proton movement directly across viral membranes to identify novel influenza virus M2 inhibitors.

Chidananda Sulli1, Soma S R Banik, Justin Schilling, Allan Moser, Xiaoxiao Xiang, Riley Payne, Antony Wanless, Sharon H Willis, Cheryl Paes, Joseph B Rucker, Benjamin J Doranz.   

Abstract

The influenza virus M2 protein is a well-validated yet underexploited proton-selective ion channel essential for influenza virus infectivity. Because M2 is a toxic viral ion channel, existing M2 inhibitors have been discovered through live virus inhibition or medicinal chemistry rather than M2-targeted high-throughput screening (HTS), and direct measurement of its activity has been limited to live cells or reconstituted lipid bilayers. Here, we describe a cell-free ion channel assay in which M2 ion channels are incorporated into virus-like particles (VLPs) and proton conductance is measured directly across the viral lipid bilayer, detecting changes in membrane potential, ion permeability, and ion channel function. Using this approach in high-throughput screening of over 100,000 compounds, we identified 19 M2-specific inhibitors, including two novel chemical scaffolds that inhibit both M2 function and influenza virus infectivity. Counterscreening for nonspecific disruption of viral bilayer ion permeability also identified a broad-spectrum antiviral compound that acts by disrupting the integrity of the viral membrane. In addition to its application to M2 and potentially other ion channels, this technology enables direct measurement of the electrochemical and biophysical characteristics of viral membranes.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23885079      PMCID: PMC3807417          DOI: 10.1128/JVI.01190-13

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  44 in total

1.  Identification of hits as matrix-2 protein inhibitors through the focused screening of a small primary amine library.

Authors:  Wenhui Hu; Shaogao Zeng; Chufang Li; Yanling Jie; Zhiyuan Li; Ling Chen
Journal:  J Med Chem       Date:  2010-05-13       Impact factor: 7.446

2.  Membrane permeability changes at early stages of influenza hemagglutinin-mediated fusion.

Authors:  V A Frolov; A Y Dunina-Barkovskaya; A V Samsonov; J Zimmerberg
Journal:  Biophys J       Date:  2003-09       Impact factor: 4.033

Review 3.  Potential-sensitive molecular probes in membranes of bioenergetic relevance.

Authors:  J C Smith
Journal:  Biochim Biophys Acta       Date:  1990-03-15

4.  The cytoplasmic tail of the influenza A virus M2 protein plays a role in viral assembly.

Authors:  Kiyoko Iwatsuki-Horimoto; Taisuke Horimoto; Takeshi Noda; Maki Kiso; Junko Maeda; Shinji Watanabe; Yukiko Muramoto; Ken Fujii; Yoshihiro Kawaoka
Journal:  J Virol       Date:  2006-06       Impact factor: 5.103

5.  Exploring the size limit of templates for inhibitors of the M2 ion channel of influenza A virus.

Authors:  María D Duque; Chunlong Ma; Eva Torres; Jun Wang; Lieve Naesens; Jordi Juárez-Jiménez; Pelayo Camps; F Javier Luque; William F DeGrado; Robert A Lamb; Lawrence H Pinto; Santiago Vázquez
Journal:  J Med Chem       Date:  2011-04-05       Impact factor: 7.446

6.  The ion channel activity of the influenza virus M2 protein affects transport through the Golgi apparatus.

Authors:  T Sakaguchi; G P Leser; R A Lamb
Journal:  J Cell Biol       Date:  1996-05       Impact factor: 10.539

7.  Design and pharmacological characterization of inhibitors of amantadine-resistant mutants of the M2 ion channel of influenza A virus.

Authors:  Victoria Balannik; Jun Wang; Yuki Ohigashi; Xianghong Jing; Emma Magavern; Robert A Lamb; William F Degrado; Lawrence H Pinto
Journal:  Biochemistry       Date:  2009-12-22       Impact factor: 3.162

8.  ANTIVIRAL ACTIVITY OF 1-ADAMANTANAMINE (AMANTADINE).

Authors:  W L DAVIES; R R GRUNERT; R F HAFF; J W MCGAHEN; E M NEUMAYER; M PAULSHOCK; J C WATTS; T R WOOD; E C HERMANN; C E HOFFMANN
Journal:  Science       Date:  1964-05-15       Impact factor: 47.728

9.  Toxicity of influenza A virus matrix protein 2 for mammalian cells is associated with its intrinsic proton-channeling activity.

Authors:  Petr O Ilyinskii; Vladimir L Gabai; Shamil R Sunyaev; Galini Thoidis; Alexander M Shneider
Journal:  Cell Cycle       Date:  2007-06-12       Impact factor: 4.534

10.  The molecular mechanism of action of the proton ionophore FCCP (carbonylcyanide p-trifluoromethoxyphenylhydrazone).

Authors:  R Benz; S McLaughlin
Journal:  Biophys J       Date:  1983-03       Impact factor: 4.033

View more
  4 in total

1.  Salinomycin Inhibits Influenza Virus Infection by Disrupting Endosomal Acidification and Viral Matrix Protein 2 Function.

Authors:  Yejin Jang; Jin Soo Shin; Yi-Seul Yoon; Yun Young Go; Hye Won Lee; Oh Seung Kwon; Sehee Park; Man-Seong Park; Meehyein Kim
Journal:  J Virol       Date:  2018-11-27       Impact factor: 5.103

2.  Thermal green protein, an extremely stable, nonaggregating fluorescent protein created by structure-guided surface engineering.

Authors:  Devin W Close; Craig Don Paul; Patricia S Langan; Matthew C J Wilce; Daouda A K Traore; Randal Halfmann; Reginaldo C Rocha; Geoffery S Waldo; Riley J Payne; Joseph B Rucker; Mark Prescott; Andrew R M Bradbury
Journal:  Proteins       Date:  2015-05-08

3.  Tauroursodeoxycholic acid (TUDCA) inhibits influenza A viral infection by disrupting viral proton channel M2.

Authors:  Ning Li; Yanxu Zhang; Shuangxiu Wu; Ruodan Xu; Zhiqing Li; Jindong Zhu; Hongliang Wang; Xiao Li; Mingyao Tian; Huijun Lu; Ningyi Jin; Chengyu Jiang
Journal:  Sci Bull (Beijing)       Date:  2018-09-01       Impact factor: 11.780

Review 4.  Put a cork in it: Plugging the M2 viral ion channel to sink influenza.

Authors:  Pouria H Jalily; Maggie C Duncan; David Fedida; Jun Wang; Ian Tietjen
Journal:  Antiviral Res       Date:  2020-03-27       Impact factor: 5.970

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.